The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth
Qian, Jing, Ma, Yanxia, Tahaney, William M, Moyer, Cassandra L, Lanier, Amanda, Hill, Jamal, Coleman, Darian, Koupaei, Negar, Hilsenbeck, Susan G, Savage, Michelle I, Page, Brent D G, Mazumdar, Abhijit, Brown, Powel H
Published in Breast cancer research : BCR (05.02.2024)
Published in Breast cancer research : BCR (05.02.2024)
Get full text
Journal Article
Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth
Qian, Jing, Ma, Yanxia, Tahaney, William M, Moyer, Cassandra L, Lanier, Amanda, Hill, Jamal, Coleman, Darian, Koupaei, Negar, Hilsenbeck, Susan G, Savage, Michelle I, Page, Brent D G, Mazumdar, Abhijit, Brown, Powel H
Published in Breast cancer research : BCR (26.03.2024)
Published in Breast cancer research : BCR (26.03.2024)
Get full text
Journal Article
Abstract P004: Targeting the RXR pathway for the prevention of triple-negative breast cancer
Moyer, Cassandra, Hill, Jamal, Coleman, Darian, Sei, Shizuko, Mohammed, Altaf, Sanders, Martin, Brown, Powel, Mazumdar, Abhijit
Published in Cancer prevention research (Philadelphia, Pa.) (01.01.2023)
Published in Cancer prevention research (Philadelphia, Pa.) (01.01.2023)
Get full text
Journal Article
IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy
Moyer, Cassandra L, Lanier, Amanda, Qian, Jing, Coleman, Darian, Hill, Jamal, Vuligonda, Vidyasagar, Sanders, Martin E, Mazumdar, Abhijit, Brown, Powel H
Published in Clinical cancer research (03.06.2024)
Published in Clinical cancer research (03.06.2024)
Get full text
Journal Article
Abstract 3966: Targeting S100A10, a SOX9 binding protein, for the treatment of triple negative breast cancer
Ma, Yanxia, Qian, Jing, Moyer, Cassandra, Lanier, Amanda, Hill, Jamal, Coleman, Darian, Hawke, David H., Mazumdar, Abhijit, Brown, Powel H.
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract PS07-07: The RXR agonist, IRX4204, delays the formation of Brca1 mutant mammary tumors via modulation of the anti-tumor immune response
Moyer, Cassandra, Coleman, Darian, Hill, Jamal, Vornik, Lana A., Savage, Michelle, Sanders, Martin, Shizuko, Sei, Mohammed, Altaf, Brown, Powel, Mazumdar, Abhijit
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article